Navigation Links
Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries
Date:11/28/2011

LONDON, November 28, 2011 /PRNewswire/ --

- Life Sciences Seasonal Appeal to Raise Funds for Camfed International

Alacrita, which is changing the face of life science consulting, is delighted to launch its Life Sciences Seasonal Appeal. Alacrita is offering the unique opportunity for individuals from the life sciences industry to bid for a two-hour, one-to-one lunch with senior figures from the pharmaceutical and venture capital industries.

The Appeal aims to raise money for Camfed International (http://www.camfed.org), which invests in the education and empowerment of women and girls in sub-Saharan Africa in an effort to fight poverty and the spread of HIV/AIDS. The charity auction is being run in partnership with the charity auction site charitybuzz.com. Bidding is open through http://www.charitybuzz.com/alacrita and closes on 19 December.

Senior figures from the life sciences industry who have kindly donated their time to the appeal include:

  • Heather Bell, Head of Corporate Strategy and Shaun Grady, Head of Business Development at AstraZeneca plc
  • Kate Bingham, Managing Partner at SV Life Sciences
  • John Brown CBE, Chairman of BTG plc, Axis-Shield plc and Non-Executive Director of Vectura plc
  • Barbara Dalton, Director of Pfizer Venture Investments
  • Deborah Harland, Partner of SR One
  • Anya König, Managing Director of the Novartis Venture Funds
  • Carole Nuechterlein, Head of Roche Venture Fund
  • Sir Richard Sykes, Chairman of The Royal Institution of Great Britain, former Rector of Imperial College London and former Chairman of GlaxoSmithKline plc
  • Ian Tomlinson, Senior Vice President Head of Worldwide Bus
    '/>"/>

SOURCE Camfed and Alacrita
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alacrita Set to Change the Face of Life Science Consulting
2. MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
3. MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries
4. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
5. Prime Therapeutics Launches Retail Medication Therapy Management Program
6. Codman Launches CERTAS™ Programmable Valve for Hydrocephalus
7. HeartSine® Technologies Launches New Global Website
8. Philips Launches HeartStart FR3 Automated External Defibrillator for Professional Responders Treating Victims of Sudden Cardiac Arrest
9. Express Scripts, Inc. Launches Senior Notes Offering
10. Actavis Launches Generic KADIAN® Capsules in the U.S.
11. Sectra Launches Support for Breast Tomosynthesis Images in PACS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader in ... partnership with RCA Medical, a subsidiary of Ascendis Health ... Each year, hundreds of millions of patients ... as organisms are transmitted from patient to patient via ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... , , ... February 18, 2010 Health,Robotics, the undisputed ... it has been recently awarded by SGS (Societe,General de ... ISO,9001:2008 norm), the globally accepted standard for companies to ...
... CARLSBAD, Calif. , Feb. 18 ... announced today that the organization has been awarded the ... management system throughout the organization. TUV SUD America Inc. ... as AutoGenomics looks to expand its increasing role in ...
Cached Medicine Technology:ISO 9001:2008 Certification Awarded to Health Robotics 2ISO 9001:2008 Certification Awarded to Health Robotics 3ISO 9001:2008 Certification Awarded to Health Robotics 4AutoGenomics Receives ISO Certification 2
(Date:1/22/2015)... Nashville, TN (PRWEB) January 22, 2015 Gabe’s Chemo ... Chemo Duck App, the first app ever created for kids with ... all Apple phones and devices, is filled with enjoyable games to ... life and treatments. The free app helps to keep kids entertained, ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... , , , DETROIT, Aug. ... injuries and illnesses, but given the abuse potential many wind up getting hooked ... This was the topic of an interview that aired today on the Rick ... Rampant was the title of the interview and it featured Narconon ...
... TSX: COM, , , VANCOUVER and DEERFIELD, ... CRME/TSX: COM) and its co-development partner Astellas Pharma US, ... single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) ... to sinus rhythm. The trial, to be called ACT ...
... , , , ... , BOSTON, Aug. 10 PAREXEL International Corporation (Nasdaq: ... Fiscal Year ended June 30, 2009. The Company has determined the ... as described in greater detail below. These changes relate to (1) ...
... N.J., Aug. 10 Pharmasset, Inc. (Nasdaq: VRUS ), ... novel drugs to treat viral infections, today reported financial results and ... , , Financial Results , ... June 30, 2009 compared to $0.5 million for the quarter ended ...
... , , Increased caseloads, ... concerns , , WASHINGTON, Aug. 10 ... approximately 4,000 HIV-treating clinicians in the United States [out of a ... survey indicating that while supportive of ongoing health care reform efforts, ...
... , , , ... launch of its national awareness campaign, Cities Go Blue for Colon Cancer ... events kicking off on September 26-27, 2009. , , ... Cancer campaign is to promote awareness about colorectal cancer, by encouraging people ...
Cached Medicine News:Health News:Narconon Graduate Lives to Tell Story of Addiction 2Health News:Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 2Health News:Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 3Health News:Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 4Health News:Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 5Health News:Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 6Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 2Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 3Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 4Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 5Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 6Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 7Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 8Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 9Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 10Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 11Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 12Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 13Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 14Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 15Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 16Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 17Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 2Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 3Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 4Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 5Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 6Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 7Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 8Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 2Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 3Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 4Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 5Health News:Cities Go Blue for Colon Cancer 2
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Firstchoice drainable pouch with softflex skin barrier, cushionfit backing, transparent odor-barrier quiet film and microporous adhesive....
Inquire...
... Protects the skin over extended wearing ... barrier is the barrier of choice ... added benefit of it being discreet ... Security and confidence assured with internal ...
Medicine Products: